Bioanalysis Zone

Conference Report: Europen Bioanalysis Forum


The European Bioanalysis Forum (EBF) is a bioanalytical discussion group comprised of European pharmaceutical companies (26 members to date). The membership shares a common vision to advance the shared understanding of topical concerns through discussion of scientific, technological and regulatory issues of bioanalytical interest. The objective of the open symposium was to reach out to the broader European and global bioanalytical community, to report back on discussions EBF member companies have during their biannual closed meetings and, going forward, to provide guidance and recommendations to the European and global bioanalytical community. Pharmaceutical and biotechnology companies, contract research organisations (CROs), academia and instrument vendors were invited to attend to exchange scientific ideas and information on topical issues of mutual concern. The symposium included sessions on assay validation, metabolite quantification, instrumentation developments and protein quantification and immunogenicity. Experts and key opinion leaders were invited as guest speakers. A total of 251 delegates attended, representing a large percentage of the European bioanalytical community. The majority of attendees represented pharmaceutical companies (36%), CROs (42%), instrument vendors (15%) and academia (4%). In addition to 18 oral presentations, 51 posters were presented and there was a well-supported vendor exposition.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.


Leave A Comment